|
James C. Greenwood, President and Chief Executive Officer, Biotechnology Industry Organization testifies before the House Committee on Science and Technology, Subcommittee on Technology and Innovation (April 23, 2009)
The Role of the SBIR and the STTR Programs in Stimulating Innovation at Small High-Tech Businesses
Read the statement.
Rachel K. King, Chief Executive Officer, Glycomimetics, Inc. testifies before the House of Representatives Committee on Small Business (April 22, 2009)
The Importance of Technology in an Economic Recovery
Read the statement.
Small Business Innovation Research (SBIR) Reauthorization Act (April 17, 2008)
Letter to the US House of Representatives regarding the SBIR Reauthorization Act (H.R. 5819)
Read the statement.
January 29, 2008 - When the House Committee on Small Business, chaired by Nydia Velazquez, held a hearing today on reauthorization of the SBIR program, the panelists generally agreed that the criteria for SBIR grant eligibility should revert to its original structure which allowed SBIR grants to support innovative biotechnology companies when more than 50% of its investors are comprised by venture capitalists, including venture funds sponsored by advocacy organizations such as the Cystic Fibrosis Foundation, whose president testified today.
The videos are up on YouTube
Testimony of all panelists and more information is posted on the Committee’s web site.
Health Advocacy Groups Seek to End Barriers in Accessing Funding for Vital Medical Research
In a letter to Congressional leaders today, 52 patient advocacy and medical specialty groups urged for the restoration of eligibility for small biotechnology companies to compete for Small Business Innovation Research (SBIR) grants, a federal program that provides a vital source of funding for new biomedical innovation. (October 18, 2007)
Read the statement.
Read the letter from health advocacy groups.
BIO to Ask Congress to Restore SBIR Grant Eligibility for Small Biotech Companies
At a Congressional roundtable, the Biotechnology Industry Organization (BIO) will ask Congress to restore eligibility for many small biotech companies to enable them to compete for Small Business Innovation Research (SBIR) grants. (October 17, 2007)
Read the press release
BIO Applauds House Passage of SBIEA
BIO hailed the passage yesterday of the Small Business Investment Expansion Act (H.R. 3567), a bill that aims to facilitate economic growth, job creation and continued American innovation. (September 28, 2007)
Read the press release
Changes in SBIR Program Threaten Biotechnology Company Funding
The Small Business Administration (SBA) provides start-up funding to small businesses in a variety of ways. One program is the Small Business Innovation Research (SBIR) program which allocates a specific percentage of federal research and development (R&D) grant money for small business applicants. This "seed" money is critical capital for emerging biotechnology companies to fund breakthrough R&D activities. In January of 2001, the SBA Office of Hearings and Appeals changed their interpretation of who qualifies for an SBIR grant to exclude any company that is venture capital-backed in excess of 51%. This new interpretation threatens an important funding source for emerging or start-up biotechnology companies. (September 24, 2007)
Read the press release
BIO Urges Congress to Allow More Companies to Compete for SBIR Grants
Testimony by Dr. Gary McGarrity, Executive Vice President of Scientific and Clinical Affairs at VIRxSYS before the House Science and Technology Subcommittee on Technology and Innovation (April 26, 2007)
Read the Testimony (361 KB PDF)
Biotech CEO Testimony Before Senate Small Business Committee
"Strengthening Participation of Small Businesses in Federal Contracting and Innovation Research Programs" (July 12, 2006)
Read Thomas Bigger's Testimony (PDF)
281 Biotech CEOs Seek SBA Fix to Continue their Medical Research
Letter to Senators Snowe and Kerry and Congressman Manzullo, Boehlert, Velázquez, and Gordon (July 26, 2005)
Read the letter (153 KB PDF)
Read the press release
Letter from NIH Director Elias A. Zerhouni M.D.
To SBA Administrator Hector V. Barreto. (June 28, 2005)
Read the letter (160 KB PDF)
Hearing on "The Importance of the Biotechnology Industry and Venture Capital Support in Innovation"
Testimony before the House Small Business Subcommittee on Rural Enterprises, Agriculture and Technology (July 27, 2005)
Read BIO's testimony (118 KB PDF)
Prepared Remarks of Mr. David N. Duncan, Ph.D. President & CEO Chlorogen, Inc.
SBA Public Hearing Testimony
On SBIR Eligibility Criteria (June 17, 2005)
Read the testimony
Greenwood Supports Bills to Fix SBA Interpretation for Grants
Statement supporting legislation introduced in the House by Sam Graves (R-MO) and in the Senate by Kit Bond (R-MO) (June 16, 2005)
Read the statement
Text of S. 1263
To amend the Small Business Act to establish eligibility requirements for business concerns to receive awards under the Small Business Innovation Research Program.
Read the Legislation (PDF)
Text of H.R. 2943
To amend the Small Business Act to establish eligibility requirements for business concerns to receive awards under the Small Business Innovation Research Program.
Read the Legislation (PDF)
BIO Fact Sheet
Changes in SBIR Program Threaten Biotechnology Company Funding (April 7, 2005)
Read the Fact Sheet
BIO Response to SBA Request for Comments
Regarding an exclusion from affiliation for venture capital companies for SBIR program eligibility (March 31, 2005)
Read the comments (137 KB PDF)
BIO Letter
From nearly 120 CEOs and biotech leaders supporting H.R. 4149 and S. 2384 (July 22, 2004)
Read the Letter (450 KB PDF)
Congressional Letter
To Senators Specter and Santorum from Members of the PA House Delegation (March 25, 2004)
Read the Letter (450 KB PDF)
Congressional Letter
From 30 Congress members urging Chairman Manzullo and Chairwoman Snowe to include a correction in SBA Reauthorization legislation (Dec 10, 2003)
Read the Letter (450 KB PDF)
Advanced Notice of Proposed Rulemaking
Federal Register notice on SBA - Volume 69, No 232 (December 3, 2004)
Read the Notice (72 KB PDF)
Final Rule
Federal Register notice on SBA SBIR Program - Volume 69, No 232 (December 3, 2004)
Read the Notice (71 KB PDF)
CBR Laboratories, Inc. Small Business Administration SBIR Ruling
No. 4423, Docket No SIZ-2000-l0-16-32 (January 10, 2001)
Read the Ruling
Cognetix, Inc. Small Business Administration SBIR Ruling
No. 4560, Docket No. SIZ-2003-04-28-26 (May 29, 2003)
Read the Ruling
SBIR Archive
Older materials on this subject are available in our archive.
Browse the Archive
| 
